Computational science leader. Accomplished computational chemist with a proven track record of successful design of novel drugs. Scientific and technical expertise in the broad area of Computational Science in Pharmaceutical Industry. Performed computational support of multiple projects in small molecule drug design through Hit ID, Lead Generation, Lead Optimization, compound selection for clinical testing and drug development. My computational chemistry contributions were reflected in multiple NDA filings of drugs, which are currently on the market.
VP of Scientific Affairs